AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 214 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,527,508 | -11.5% | 102,122 | +1.2% | 0.00% | 0.0% |
| Q2 2023 | $2,856,978 | +135946.6% | 100,882 | +10.4% | 0.00% | 0.0% |
| Q1 2023 | $2,100 | -16.2% | 91,405 | +2.4% | 0.00% | 0.0% |
| Q4 2022 | $2,507 | -99.9% | 89,268 | +2.7% | 0.00% | -25.0% |
| Q3 2022 | $2,459,000 | +35.9% | 86,946 | +6.5% | 0.00% | +33.3% |
| Q2 2022 | $1,810,000 | -17.6% | 81,655 | +8.2% | 0.00% | 0.0% |
| Q1 2022 | $2,197,000 | -18.3% | 75,456 | -7.7% | 0.00% | 0.0% |
| Q4 2021 | $2,688,000 | -32.3% | 81,765 | -4.9% | 0.00% | -40.0% |
| Q3 2021 | $3,969,000 | -18.7% | 86,004 | -2.9% | 0.01% | -16.7% |
| Q2 2021 | $4,880,000 | +36.5% | 88,549 | +27.9% | 0.01% | +20.0% |
| Q1 2021 | $3,574,000 | +16.0% | 69,218 | -2.6% | 0.01% | +25.0% |
| Q4 2020 | $3,080,000 | +30.1% | 71,084 | +5.1% | 0.00% | 0.0% |
| Q3 2020 | $2,368,000 | -36.5% | 67,654 | -3.1% | 0.00% | -33.3% |
| Q2 2020 | $3,732,000 | +64.7% | 69,783 | +9.3% | 0.01% | +20.0% |
| Q1 2020 | $2,266,000 | -2.3% | 63,867 | +31.5% | 0.01% | +25.0% |
| Q4 2019 | $2,320,000 | +60.9% | 48,586 | +9.2% | 0.00% | +33.3% |
| Q3 2019 | $1,442,000 | -33.0% | 44,500 | +3.2% | 0.00% | -25.0% |
| Q2 2019 | $2,151,000 | -36.9% | 43,132 | -14.7% | 0.00% | -42.9% |
| Q1 2019 | $3,410,000 | +45.5% | 50,563 | -0.5% | 0.01% | +40.0% |
| Q4 2018 | $2,343,000 | -42.3% | 50,808 | -3.4% | 0.01% | -37.5% |
| Q3 2018 | $4,058,000 | -9.7% | 52,616 | -1.4% | 0.01% | -11.1% |
| Q2 2018 | $4,495,000 | +9.6% | 53,362 | +6.4% | 0.01% | 0.0% |
| Q1 2018 | $4,101,000 | +59.0% | 50,151 | +11.1% | 0.01% | +80.0% |
| Q4 2017 | $2,580,000 | -15.6% | 45,122 | -1.4% | 0.01% | -28.6% |
| Q3 2017 | $3,056,000 | +28.3% | 45,785 | -1.1% | 0.01% | +40.0% |
| Q2 2017 | $2,381,000 | +10.5% | 46,282 | +25.4% | 0.01% | 0.0% |
| Q1 2017 | $2,155,000 | +43.7% | 36,908 | +2.7% | 0.01% | +25.0% |
| Q4 2016 | $1,500,000 | -4.7% | 35,947 | +20.6% | 0.00% | 0.0% |
| Q3 2016 | $1,574,000 | +30.4% | 29,800 | +3.4% | 0.00% | 0.0% |
| Q2 2016 | $1,207,000 | +22.7% | 28,815 | +18.9% | 0.00% | +33.3% |
| Q1 2016 | $984,000 | -39.3% | 24,241 | -2.8% | 0.00% | -40.0% |
| Q4 2015 | $1,620,000 | -5.7% | 24,947 | +2.5% | 0.01% | -16.7% |
| Q3 2015 | $1,718,000 | -34.5% | 24,342 | +3.1% | 0.01% | -25.0% |
| Q2 2015 | $2,624,000 | +76.9% | 23,606 | +50.1% | 0.01% | +100.0% |
| Q1 2015 | $1,483,000 | +4.1% | 15,726 | +23.6% | 0.00% | 0.0% |
| Q4 2014 | $1,425,000 | +104.7% | 12,721 | +12.1% | 0.00% | +100.0% |
| Q3 2014 | $696,000 | +26.8% | 11,350 | -5.3% | 0.00% | 0.0% |
| Q2 2014 | $549,000 | – | 11,990 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |